EAM
HZNP

EFG Asset Management’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

EFG Asset Management’s Portfolio HZNP Stock Details HZNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-26,070
Closed -$2.96M – 194
2022
Q4 		$2.96M Sell
26,070
-67,415
-72% -$5.6M 0.66% 54
2022
Q3 		$5.79M Buy
93,485
+1,675
+2% +$117K 1.34% 14
2022
Q2 		$7.33M Sell
91,810
-4,089
-4% -$387K 1.54% 9
2022
Q1 		$10.1M Buy
+95,899
New +$9.35M 1.51% 9

Other funds holding HZNP

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $16.4B AUM 55.44% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
DKCM
Davidson Kempner Capital Management New York $8.42B AUM 61.81% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

EFG Asset Management's HZNP Position: Q1 2023 in Review

EFG Asset Management sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q1 2023, closing a stake of 26,070 shares — an estimated $2.96M sold.

EFG Asset Management first reported a position in HZNP in Q1 2022 and held it in 4 quarters. The position peaked at $10.1M in Q1 2022. 552 funds tracked by Wall St. Rank hold HZNP as of Q1 2023.

  • EFG Asset Management reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q1 2023 after selling out during the quarter.
  • EFG Asset Management sold 26,070 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q1 2023, an estimated $2.96M.
  • EFG Asset Management first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q1 2022 and held it in 4 quarters.
  • EFG Asset Management's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $10.1M in Q1 2022.
  • 552 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q1 2023.

Based on EFG Asset Management's 13F filing for Q1 2023, filed 27 Apr 2023.